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Abstract
Background: Streptococcosis is an important disease of tilapia throughout the world. In Malaysia, streptococcosis
outbreak was commonly reported during the 3-month period of high water temperature between April and July.
This study describes the duration of protection following single and double booster dose regimes against
streptococcosis in tilapia using a feed-based vaccine containing formalin-killed Streptococcus agalactiae. A total of
510 tilapias of 120 ± 10 g were selected and divided into 3 groups. Fish of Group 1 were vaccinated at weeks 0 and
2 (single booster group) while fish of Group 2 were vaccinated at weeks 0, 2 and 6 (double booster group) with a
feed-based vaccine against streptococcosis. Fish of Group 3 was not vaccinated. Serum samples were collected
weekly to determine the antibody level while samples of eye, brain and kidney were collected for bacterial
isolation. At week 10, all fish were challenged with live S. agalactiae and the survival rate was determined.
Results: Both vaccinated groups showed significant (p < 0.05) increase in the antibody levels following the first
booster dose, which lasted until week 6. Group 2 showed consistent high level of antibody following the second
booster dose at week 6 and remained high until week 12. Challenge trial at week 10 resulted in 45 %, 70 % and
0 % rate of survival for Groups 1, 2 and 3, respectively.
Conclusion: Double booster regime is most suitable to be applied for feed-based vaccination against streptococcosis
prior to the start of the hot season.
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Background
Tilapia is one of the most cultured fish species in the
world with China, Egypt and Philippines as major pro-
ducers [1]. However, with extensive aquaculture activity,
farmed fish are affected by environmental fluctuations
and husbandry management, which cause stress to the
fish and contribute to infections by a wide variety of
pathogens [2].
Streptococcosis is one of the major diseases of fish that
leads to staggering losses. It is caused by two main species;
Streptococcus agalactiae and S. iniae, affecting a wide
range of both freshwater and marine fish species. In
Malaysia, most outbreaks of streptococcosis in tilapia are
caused by S. agalactiae that are influenced by the high
water temperature above 31 °C during the hot months of
April to July [3].
Vaccination is the most viable option to control
streptococcosis in fish [2]. Injection is the most potent
route of vaccination as it produces a stronger immune
response compared to other routes of vaccination such
as spray and immersion [4, 5]. However, the injection
method requires a certain level of manpower, technical
prowess and proper equipment. Therefore, a more
practical route of vaccination is the oral route as there
is no direct contact between handler and fish [6]. Fur-
thermore, no specific technical skill is needed to apply
the vaccine to the fish. However, oral vaccination re-
sults in lower efficacy and shorter period of protection
[2]. This paper determines the duration of systemic
IgM response and efficacy of the newly developed
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Red tilapia (Oreochromis mossambicus x O. niloticus)
fingerlings of approximately 2 in. in length were ac-
quired from a hatchery in Tapah, Perak. Upon arrival at
the experimental station, the fish were kept in 2
thousand litres capacity fibreglass tanks at 27 °C with
running water and aerators. The fish were fed ad-libi-
tum twice daily until they reached approximately 100 g
bodyweight. Prior to the start of the experiment, the fish
were screened for bacterial colonization and antibody
level to ensure that they were free from infection by S.
agalactiae [7].
Bacterial culture
Streptococcus agalactiae strain TP 749B was used in this
study. The strain was isolated from an outbreak of strep-
tococcosis in cage-cultured red tilapia in 2007 at Sungai
Pahang, Malaysia [8]. The stock that was kept in glycerol
at −20 °C was thawed to room temperature overnight
prior to use.
Formalin-killed bacteria
The formalin-killed bacteria for vaccine preparation
were prepared according to the method of Firdaus-Nawi
et al. [6]. Briefly, stock culture of S. agalactiae (TP 749B)
was streaked onto 5 % blood agar and incubated at
30 °C for 24 h. Propagation of S. agalactiae was done
by inoculating 10 colonies from the blood agar into
Brain Heart Infusion Broth (BHIB) and incubated in a
shaker incubator at 150RPM, 30 °C for 24 h. Follow-
ing incubation, the bacterial concentration was deter-
mined using the standard plate count technique [9].
The S. agalactiae cells were then harvested by centri-
fugation (6000 × g, 10 min) and washed with
phosphate-buffered saline (PBS) followed by centrifu-
gation (6000 × g, 10 min) for 3 times to remove the
medium residue. Afterwards, 10 % buffered formalin
was added into the washed pellet to reach a final
concentration of 0.5 % formalin before the mixture
was kept overnight at 4 °C to kill the bacteria. Then,
the bacteria cells were washed again with PBS with
centrifugation (6000 × g, 10 min) for 3 times to re-
move the formalin residue from the culture. The
formalin-killed bacteria were re-suspended in sterile
PBS solution to obtain the final bacteria concentra-
tion of 6.7 × 107 CFU/mL. The suspension was
streaked onto blood agar and incubated for 24 h at
37 °C to ensure that all S. agalactiae were killed. To
improve the vaccine antigenicity, Freund’s incomplete
adjuvant (FIA) was added to a final concentration of
10 % before it was thoroughly mixed with pelletted
feed to give a final concentration of 106 cells/kg of
feed [6].
Experimental design
A total of 510 red tilapia hybrid (Oreochromis mossambi-
cus x O. niloticus) fish with an average weight of 120 ±
10 g were selected and equally divided into 3 groups; the
single booster, double booster and control groups. Ten
fish were placed into each of the 51 glass aquaria con-
taining 100 L water at an average water temperature of
29 °C, provided with aeration and running water with
12-h light and dark periods. The fish were fed with com-
mercial feed (Cargill, Malaysia).
At the start of the experiment, the vaccine was or-
ally administered on day 0 by feeding the fish with
feed containing the vaccine at 4 % body weight twice;
at 8 am and 3 pm. To ensure that all treated fish re-
ceived the feed-based vaccine, they were deprived of
feed for 24 h and while feeding, the feed-based vac-
cine was distributed slowly and evenly in each glass
aquaria. For single booster group, vaccination was re-
peated on day 14, while the double booster group re-
ceived the feed-based vaccine on days 14 and 42. The
unvaccinated control group was given regular com-
mercial feed without the vaccine. On other days, all
fish were fed with normal commercial pellet through-
out the 14-week study period.
Serum samples to determine the antibody level were
collected from 10 fish of each group at weekly inter-
vals beginning from day 0 until day 98 when the ex-
periment was terminated. The same procedure was
replicated and data from both experiments were
pooled and analysed.
Challenge trial
The challenge trial was carried out at week 10 of the ex-
periment. Twenty fish from each of the three groups were
transferred into 6 glass aquaria without running water.
These 20 selected fish from each group were kept in 2
aquaria at the rate of 10 fish per aquarium as duplicate. A
fresh inoculum containing live virulent cells of S. agalac-
tiae strain NF958 at a concentration of 1.0 × 109 CFU/ml
was prepared before 0.5 ml of the inoculum was injected
intraperitoneal (i.p.) into each fish. The fish were anaes-
thetized with Tricaine methanesulfonate (MS-222) prior
to the i.p. injection [6]. After challenged, all fish were
closely observed at hourly intervals for behavioural and
physical changes. Fish that died within the first 6 h were
excluded from the experiment while fish that showed ad-
vanced clinical signs of the infection were euthanized. At
the end of day 7 post-challenge, all surviving fish were
killed by an overdose of MS-222. They were subjected to
post-mortem examination before samples of brain, eye
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and kidneys were collected for bacterial isolation. The
level of protection or relative percentage survival (RPS)
value was then determined [10].
RPS ¼ 1  ð% immunized group mortality=
% control group mortalityÞ  100
Bacterial isolation
Organ samples were streaked onto blood agar and were
incubated at 37 °C for 18 to 24 h. Following incubation
dominant colonies were sub-cultured to obtain pure col-
onies before they were subjected to Gram staining, oxi-
dase and catalase tests. Isolates that were Gram-positive,
cocci shaped and catalase negative were subjected to
API 20 STREP bacteria identification kit (BioMerieux,
France). The Gram-positive cocci but catalase positive
were subjected to API STAPH (BioMerieux, France).
Similarly, Gram-negative isolates, which were oxidase
negative, were subjected to API 20E while those that
were oxidase positive were subjected to API 20NE (Bio-
Merieux, France). The API colour codes were referred to
the APILAB PLUS program (BioMerieux, France) for
species and genus determination of the isolates. Cultures
that were identified as S. agalactiae by API20 STREP
were further confirmed by API 20STREP and BLAST
analysis of 16S rRNA sequence of PCR product [11].
Enzyme-linked immunosorbent assay
All serum samples were subjected to indirect ELISA
[12, 13] that detected the IgM. Coating antigen was
prepared by culturing S. agalactiae into brain-heart
infusion broth and incubated for 24 h in shaker incu-
bator at 30 °C, 150 rpm. Bacterial concentration was
determined using standard plate count technique
before harvested by centrifugation and washed with phos-
phate buffer saline (PBS). The bacterial pellet was then re-
suspended in carbonate-bicarbonate buffer (pH 9.6) to a
final concentration of 2.5 × 105 CFU/ml. The suspension
was boiled in water bath at 97 °C for 20 min to kill the
bacteria and cooled to room temperature prior to use as
coating antigen.
Flat-bottomed microtitre plates were coated with
100 μL coating antigen and were left overnight at 4 °C be-
fore washed twice with PBS + 0.05 % Tween 20 (PBST).
Then, 200 μL of 1 % bovine serum albumin (BSA) was
added to block unspecific binding sites and incubated in
37 °C for 1 h. This was followed by adding 100 μL of
serum (1:1000) into the reaction and similarly incubated.
After that, 100 μL of goat anti-tilapia hyperimmune
serum, diluted 1:10,000 was added and incubated again.
Next, 100 μL of conjugated rabbit anti-goat IgM-
horseradish peroxidase (Nordic, Netherland) diluted to
1:10,000 was added into the reaction and incubated. After
washed for three times with PBST, bound conjugates were
detected by adding 100 μL of TMB One substrate solution
(Promega, USA) before the reaction was stopped with
0.2 mol/L sulphuric acid. The absorbance was determined
at 450 nm wavelength (Bio-Rad, USA).
The cut-off value is the highest possible true-positive
rate [14] that is used as an indication of protection. It
was determined by performing ELISA on 100 serum
samples collected from non-immunized tilapia obtained
from farms that had no history of streptococcosis infec-
tion and did not practice vaccination against the target
organism. After subtracting the blank wells, the average
OD value was times 2 to get the cut-off value of 0.2 OD.
Statistical analysis
The significance value of the results was calculated by
using one way analysis of variance (ANOVA) employed
by Tukey HSD in Statistix 9 software (Analytical soft-




The serum IgM antibody levels of all groups prior to
vaccination showed insignificant (p > 0.05) differences.
Following vaccination, both vaccinated groups showed
significantly (p < 0.05) higher IgM levels compared to
the control group. Following the first booster dose at
week 2, the increasing pattern continued for both vacci-
nated groups and reached peak at week 3. The level,
however, started to decrease insignificantly (p > 0.05) in
the following week but significantly (p < 0.05) thereafter
to reach the non-protective cut-off value (p > 0.05) at
weeks 5 and 6 (Fig. 1). In the first 6 weeks post-
vaccination, both vaccinated groups showed insignifi-
cantly (p > 0.05) high IgM value. However, following sec-
ond booster in week 6, the antibody level significantly
(p < 0.05) increased again to reach peak at week 8 before
declining thereafter until week 12 (Fig. 1). The vacci-
nated group that received a single booster showed
gradual decline in IgM levels to reach the same level
(p > 0.05) as the cut-off value by week 7 and below the
cut-off value thereafter until the end of the experimental
period. At time of challenge in week 10, the IgM level of
the double booster group was significantly (p < 0.05)
higher while the single booster and control groups were
significantly (p < 0.05) lower than the protective cut-off
value (Fig. 1).
Challenge trial
Following intraperitoneal challenge, fish mortality was ob-
served among the control group as early as 24 h post-
challenge. Clinical symptoms were apparent in the control
group, which included lethargy, exophthalmia, erratic
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swimming, inflammation at injection area and loss of ap-
petite while few vaccinated fish showed signs of lethargy
and loss of appetite. At the end of day 7 post-challenge,
none of the unvaccinated control fish had survived com-
pared to 45 % and 70 % survival rates of single and double
booster vaccinated fish, respectively (Table 1).
Post-mortem examinations revealed congested kidney,
enlarged spleen, pale liver and soft, watery brain. Hae-
morrhages were also registered in various organs includ-
ing liver, gastrointestinal organs and brain.
Bacterial isolation
Streptococcus agalactiae was successfully re-isolated
from the brain, eye and kidney of all dead fish. The
presence of clear zone around cultured colonies was
suggestive of β-haemolytic S. agalactiae that was con-
firmed by BLAST analysis of 16S rRNA sequence of
PCR product.
Discussion
As development in aquaculture industry continues to ex-
pand, many vaccines against many diseases are made
available with the purpose of controlling disease out-
breaks. Commercial vaccines for tilapia against strepto-
coccosis are currently available in many countries and
are widely used. The most common type of vaccine for
streptococcosis is the injectable vaccine, administered
via intraperitoneal route as it provides the best protec-
tion against streptococcosis. Immersion vaccines such as
AQUAVAX™ and GARVETIL™ (Intervet Pty. Ltd.) are
Fig. 1 Serum antibody (IgM) response following oral vaccination with a feed-based vaccine. Double booster at weeks 2 and 6 prolonged the high
antibody levels for up to 12 weeks compared to the single booster at week 2 that lasted 6 weeks
Table 1 Comparative fish mortality, survival and relative percentage survival (RPS) between controls unvaccinated fish, fish vaccinated with
single booster, and fish vaccinated with double booster regimes followed by intraperitoneal challenge with 0.5 mL of 1.0 × 109 CFU/mL of
live Streptococcus agalactiae
Group Number of Fish Mortality (n) Post-challenge Survival RPS
D1 D2 D3 D4 D5 D6 D7 Rate (%)
Single Booster 20 6 3 0 1 1 0 0 45 45b
Double Booster 20 3 2 0 1 0 0 0 70 70c
Control 20 7 5 3 3 2 0 0 0 0a
a,b,cDifferent superscripts indicate significant difference (p < 0.05)
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available and are claimed to be more practical for admin-
istration but lower in efficacy [5]. The focus of these com-
mercial vaccines, however, was mainly for large farms that
can afford high manpower, technicality and facilities for
carrying out such vaccinations. Small-scale private farmers
in Southeast Asia such as Vietnam, Malaysia, Indonesia
and Thailand, however, are unlikely to be able to afford
labor-intensive vaccine protocols requiring special equip-
ment. They, therefore, require an easier, cost effective,
user friendly and less stressful method of vaccination,
which is what oral vaccination can provide [14]. Further-
more, large scale fish producers can also benefit from oral
vaccination since an effective, feed-based vaccine could
greatly reduce stress in the production fish by avoiding
handling during vaccination and lower the cost associated
with manpower and equipment.
It is well documented that different routes of vaccin-
ation give different intensity of immune response and
thus, different vaccine efficacy [13]. Vaccination via intra-
peritoneal and intramuscular injections triggers a systemic
immune response with high antibody levels in a short
period of time. This provides longer protection compared
to immersion and oral exposure that triggers local muco-
sal immunity [15, 16]. Nevertheless, if sufficient amount
of antigen is managed to be transported and reach the end
gut segment of fish such as carp, both local and systemic
immune responses are induced [17]. The second gut seg-
ment of fish especially grouper plays an important role in
oral vaccination as it participates in the transportation and
presentation of antigen from intestinal lumen to intra-
epithelial macrophages [7]. These macrophages ingest the
antigen presented by this route and remigrate from the in-
testine to lymphoid organs mainly the spleen and kidney
before initiating systemic immune response [17]. Similar
mechanisms are believed to occur in tilapia.
Our earlier study revealed that feed-based bacterin
without adjuvant was able to stimulate IgM response for
a brief period of 3 weeks [6]. Addition of incomplete
Freund’s adjuvant was able to prolong the response to
6 weeks but was not long enough to cover the 3-month
critical period. Therefore, in this study, different oral
vaccination regimes were tested in trying to maintain
immune response and protective efficacy to cover the 3-
month critical period. Administration of second booster
at week 6 resulted in a significant increase in the level of
serum IgM for up to week 12, covering the 3-month
period required for protection of tilapia during the hot
months of April to July. This was further clarified fol-
lowing challenge at week 10 when 45 % and 70 % of the
single booster and double booster groups survived, re-
spectively. Therefore, double booster provided longer
period of high antibody titre that protected at least 70 %
of the fish. This is in agreement with earlier studies that
show that a repetition of vaccine dosage or booster dose
provides better immune responses and lasting protection
[18, 19].
A vaccine that provides 70 % protection is considered
a good vaccine, but an excellent vaccine provides >80 %
protection [20]. Furthermore, oral vaccination stimulates
both mucosal and systemic immune responses, which is
an advantage since natural streptococcosis involves en-
trance of the pathogen through mucosal organs of
mouth and skin before entering the blood stream [21].
Naturally, the pathogens initially encounter the mucosal
barrier of skin and gut lining before reaching the blood
stream. Many studies have highlighted on the presence
of some key components of mucosal immunity, particu-
larly the IgT or IgZ antibody that are associated with
mucosal immunity in fish. Furthermore, the role of in-
testinal T cells and their functions, particularly in anti-
gen uptake mechanisms at mucosal surfaces has been
highlighted, which is important in mucosal vaccination
strategies [22]. Similarly, a study in grouper revealed that
oral administrations of antigen stimulate the gut-
associated lymphoid tissue of the intestine leading to
higher level of IgM [7].
Conclusion
In conclusion, oral vaccination using feed-based vaccine
containing formalin-killed bacteria is a viable option in
tilapia vaccination against streptococcosis as it can pro-
vide systemic immune response against S. agalactiae.
Administration of second booster dose provides longer
period of protection that last for at least 12 weeks at a
rate of 70 % protection.
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